Francesco Merli
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment 115
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 39
- Neurology top 1%
- CNS Lymphoma Diagnosis and Treatment 35
- Oncology top 1%
- Viral-associated cancers and disorders 40
-
- Medical Imaging Techniques and Applications 10
-
- Lung Cancer Treatments and Mutations 34
-
- Acute Lymphoblastic Leukemia research 13
-
- Cutaneous lymphoproliferative disorders research 9
- Co-authors
- Stefano LuminariCaterina StelitanoMassimo FedericoUmberto VitoloLuigi RigacciLuigi MarcheselliFrancesco Di RaimondoEmilio Iannitto
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Francesco Merli
152 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Pathology and Forensic Medicine 3.4k
- Genetics 871
- Neurology 1.2k
- Oncology 1.8k
- Radiology, Nuclear Medicine and Imaging 912
Countries citing papers authored by Francesco Merli
This map shows the geographic impact of Francesco Merli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Merli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Merli more than expected).
Fields of papers citing papers by Francesco Merli
This network shows the impact of papers produced by Francesco Merli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Merli. The network helps show where Francesco Merli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Francesco Merli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 22 | |
| 6 | 2020 | 12 | |
| 7 | 2019 | 11 | |
| 8 | 2018 | 0 | |
| 9 | 2017 | 3 | |
| 10 | 2015 | 4 | |
| 11 | 2014 | 137 | |
| 12 | 2013 | 110 | |
| 13 | 2012 | 7 | |
| 14 | 2011 | 4 | |
| 15 | Early Interim 2-[ 18 F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Studybreakdown → | 2007 | 552 |
| 16 | 2007 | 33 | |
| 17 | 2005 | 20 | |
| 18 | 2003 | 20 | |
| 19 | 1995 | 16 | |
| 20 | 1989 | 6 |
About Francesco Merli
Francesco Merli is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 157 papers that have together received 4.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (115 papers), Viral-associated cancers and disorders (40 papers), Chronic Lymphocytic Leukemia Research (39 papers), CNS Lymphoma Diagnosis and Treatment (35 papers), Lung Cancer Treatments and Mutations (34 papers), Acute Lymphoblastic Leukemia research (13 papers), Medical Imaging Techniques and Applications (10 papers) and Cutaneous lymphoproliferative disorders research (9 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.4k citations), Genetics (871 citations) and Neurology (1.2k citations). Francesco Merli has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Stefano Luminari, Caterina Stelitano, Massimo Federico, Umberto Vitolo, Luigi Rigacci, Luigi Marcheselli, Francesco Di Raimondo, Emilio Iannitto, Paolo G. Gobbi and Alessandro Levis. Their work appears in journals such as Blood, Journal of Clinical Oncology, Hematological Oncology, Cancer and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.